| 3.78 Data as of Jun 18 |  +0.03 / +0.80%Today’s Change | 3.37 Today|||52-Week Range 5.47 | -7.80% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $86.0M |
Agenus, Inc. 3 Forbes Road Lexington Massachusetts 02421-7305 |
| Mutual fund holders | 7.78% |
| Individual stakeholders | 7.04% |
| Other institutional | 21.45% |
| Garo H. Armen, PhD | Chairman & Chief Executive Officer |
| Christine M. Klaskin, CPA | VP, Chief Financial & Accounting Officer |
| Marcel Rozencweig, MD | Head-Clinical Development |
| Kerry A. Wentworth | VP-Regulatory Affairs, Clinical & Quality |
| John Cerio | Vice President-Human Resources & Administration |
.
